IL22 and breast carcinoma: Matrix metalloproteinase-2 (MMP-2) and MMP-9 have been suggested to promote the invasion of breast cancer cells [30,31] and we thus reasoned that these factors could be mediators of the invasive potential of breast cancer cells through IL-22.